Dnastar, Inc.
Madison, WI
- UEI
- MM8CFNUNTBL7
- CAGE
- 0KRF2
- Primary NAICS
- 513210 Software Publishers
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1202 Ann St, Madison, WI 53713, USA
- Website
- dnastar.com
- Founded
- 1984
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $31,750 |
| FY2025 | $115,445 |
| FY2024 | $123,674 |
| FY2023 | $149,032 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Defense Health Agency | $23,500 | |
| 2 | Department of Health and Human Services | $8,250 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| GSL Biotech, LLC | — | 513210 Software Publishers |
| Gene Codes Corp | Ann Arbor, MI | 513210 Software Publishers |
| Biomatters LIMITED | — | — |
| Genedata (Usa), Inc. | Lexington, MA | 513210 Software Publishers |
| Sentieon Inc. | San Jose, CA | 513210 Software Publishers |
About the company
Dnastar, Inc. is a for-profit Subchapter S Corporation based in Madison, Wisconsin, specializing in bioinformatics software solutions for life science researchers. The company's primary offering is the Lasergene suite of genomics and molecular biology software, which provides advanced computational tools for sequence assembly, annotation, analysis, and management. Dnastar, Inc. has established itself as a key provider of software licenses, technical support, and maintenance services to various federal agencies, particularly within the biomedical research domain.
The company has secured numerous federal contract awards primarily from agencies within the Department of Health and Human Services, including the National Institutes of Health (NIH) and its various institutes such as the National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development, and National Institute of Environmental Health Sciences. Additional federal contract awards have come from the U.S. Department of Agriculture, Department of Defense, and Department of the Navy. Most of these contracts are firm fixed-price purchase orders for Lasergene software site license renewals, with contract values ranging from approximately $10,000 to $142,500. While the majority of these contracts had no set-aside designation, one contract with the Office of Logistics and Acquisition Operations was designated as a total small business set-aside. The contracts consistently involve providing software licenses, technical support, maintenance services, and software updates to support research efforts across various scientific disciplines.
Dnastar, Inc. has also been awarded federal grants, with a notable recent grant from the National Institute of General Medical Sciences focused on developing advanced software for antibody repertoire characterization. This grant, awarded on August 29, 2023, with an ultimate completion date of July 31, 2026, aims to create a software suite that bridges technological gaps in DNA/RNA sequencing, protein structure modeling, and computational analysis. The grant proposal emphasizes the potential to improve human health through advanced computational tools that can help decipher antibody repertoires, potentially contributing to better clinical decision-making, diagnostics, and therapeutics. The project appears to be a direct-to-phase II application that leverages Dnastar's expertise in developing sophisticated bioinformatics software solutions for complex scientific research challenges.
SBA capabilities narrative
DNA sequence assembly and analysis software on Windows and Macintosh computers; microarray gene expression software; software tools for geneticists and molecular biologists
Quick answers
Is Dnastar, Inc. registered in SAM.gov?
Yes. Dnastar, Inc.'s SAM.gov registration is active through November 11, 2026.
How much has Dnastar, Inc. received in federal contracts?
Federal contracts obligated $115,445 to Dnastar, Inc. in fiscal year 2025 and $419,901 in fiscal years 2023 through 2027.
What is Dnastar, Inc.'s most recent federal award?
Dnastar, Inc.'s most recent federal contract award is Dnastar lasergene site license renewal.(ambis #2266368) (75N93025P01110), from National Institute of Allergy and Infectious Diseases (NIH), on September 30, 2025.
On GovTribe
See Dnastar, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors